Dr Olaf Stange to head up Bayer Technology in Singapore
pharmafile | March 3, 2010 | Appointment | Manufacturing and Production | Bayer Technology Services, appointment, manufacturing and production
Bayer has appointed Dr Olaf Stange to head up its new Southeast Asia regional office for Bayer Technology Services (BTS) in Singapore.
He was previously managing director of Bayer’s Ehrfeld Mikrotechnik BTS, a role that will now be filled by Dr Joachim Heck.
Heck began his professional career at Hoechst AG in Frankfurt, subsequently joining Aventis Research & Technologies, Axiva GmbH and most recently Resources Technologies Management GmbH based in Frankfurt.
Meanwhile, Stange has led BTS subsidiary Ehrfeld Mikrotechnik BTS since 2004, expanding it during that time into one of the world’s leading suppliers in the field of microprocess technology.
Bayer Technology Services offers chemical/pharmaceutical plant services, employing almost 2,600 people worldwide, with headquarters in Leverkusen, Germany and regional offices in Belgium, China, India, Mexico, Switzerland, the UAE and the US.
BTS managing director Achim Noack said: “Serving our customers locally is part of the growth strategy of BTS. The presence of the regional office in Singapore now enables us to also offer tailored solutions for our customers in the chemical and pharmaceutical industries in Southeast Asia.”
BTS plans to open additional branch offices later this year in Brazil and Russia.
Related Content

Rotzinger launches modular filling and capping platform for over-the-counter products
Rotzinger PharmaPack has launched a new filling and capping platform called VarioFill, designed to handle …

David Wheadon appointed to board of directors at Seaport Therapeutics
This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.

Myeloma UK reveals new Director of Research appointment
UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …






